BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2438320)

  • 1. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
    Okumura K; Waldo AL
    J Am Coll Cardiol; 1987 Jun; 9(6):1332-8. PubMed ID: 2438320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    J Cardiovasc Pharmacol; 1988 May; 11(5):573-80. PubMed ID: 2455844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
    Wu KM; Hoffman BF
    Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of interruption of atrial flutter by moricizine. Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter.
    Ortiz J; Nozaki A; Shimizu A; Khrestian C; Rudy Y; Waldo AL
    Circulation; 1994 Jun; 89(6):2860-9. PubMed ID: 8205702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model.
    Shimizu A; Kaibara M; Centurion OA; Kapuku G; Hirata T; Fukatani M; Yano K; Hashiba K
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):656-62. PubMed ID: 7681913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway.
    Schoels W; Yang H; Gough WB; el-Sherif N
    Circ Res; 1991 Apr; 68(4):1117-26. PubMed ID: 2009611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new animal model of atrial flutter.
    Pagé PL; Plumb VJ; Okumura K; Waldo AL
    J Am Coll Cardiol; 1986 Oct; 8(4):872-9. PubMed ID: 3760359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
    Pagé PL; Hassanalizadeh H; Cardinal R
    Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral N-acetylprocainamide compared to quinidine plus digoxin in the chronic suppression of atrial flutter in humans.
    Feld GK; Nademanee K; Noll E; Singh BN
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):191-8. PubMed ID: 2484856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of Atrial Flutter and Fibrillation by K201's Metabolite M-II: Studies in the Canine Sterile Pericarditis Model.
    Sadrpour SA; Serhal M; Khrestian CM; Lee S; Fields T; Dittrich HC; Waldo AL
    J Cardiovasc Pharmacol; 2015 May; 65(5):494-9. PubMed ID: 25636078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circus movement atrial flutter in canine sterile pericarditis model. Activation patterns during entrainment and termination of single-loop reentry in vivo.
    Schoels W; Restivo M; Caref EB; Gough WB; el-Sherif N
    Circulation; 1991 May; 83(5):1716-30. PubMed ID: 2022026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
    Inoue H; Yamashita T; Nozaki A; Sugimoto T
    J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic and electrophysiologic effects of intravenous ibutilide and sotalol in the canine sterile pericarditis model.
    Buchanan LV; LeMay RJ; Walters RR; Hsu CY; Brunden MN; Gibson JK
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):113-9. PubMed ID: 8853021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
    Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial activation sequence during atrial flutter in the canine pericarditis model and its effects on the polarity of the flutter wave in the electrocardiogram.
    Okumura K; Plumb VJ; Pagé PL; Waldo AL
    J Am Coll Cardiol; 1991 Feb; 17(2):509-18. PubMed ID: 1991911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model.
    Ortiz J; Igarashi M; Gonzalez HX; Laurita K; Rudy Y; Waldo AL
    Circulation; 1993 Oct; 88(4 Pt 1):1866-77. PubMed ID: 8403332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation patterns in experimental canine atrial flutter produced by right atrial crush injury.
    Feld GK; Shahandeh-Rad F
    J Am Coll Cardiol; 1992 Aug; 20(2):441-51. PubMed ID: 1634684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
    Singh BN; Feld G; Nademanee K
    Angiology; 1986 Dec; 37(12 Pt 2):930-8. PubMed ID: 2433967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.